Taken together, our observations confirm that overexpression of mHtt in neuronal cells significantly suppresses the endogenous level of miR-302, which provides a novel mechanism for mHtt-impaired insulin signaling and contributes to the development of new approaches for treating HD in future. This evidence concerns the gene INS and Huntington disease.